RE:Meir Wins in Any ComparisonSanspeine, these made up comparisons are completely hypothetical. "Has Medison been in Canada it would have 2 Billion in sales", ummm nope Meir may know the Israel market but not the Canadian. You can't just multiply the sales in one country with a completely different pharma landscape in another by the population of a bigger country and say that will be the new sales multiple. Thats just stupid, did your parents pay your way through school like the hot girl from Full House?
Also why does everyone keep only referencing sales. Who cares about sales if you can't turn those sales into profits. Hey you know who else had a ton of sales Valeant, you know who else, Concordia. How are those companies doing? Sales mean nothing without the ability to turn them into profits and that is something Meir has not proven he can do. Goodman has proven that in spades. Oh and you mention that Paladin did not pay a dividend and implied that Medison is better because supposedly it does. Why would Knight raise money to then turn around and give that same money back in dividends, to then have to raise money again to acquire companies for growth. I'm sure the Paladin shareholders preferred they didn't get dividends and were only rewarded by the measily 9300% share price increase if you held from beginning to end.